169 related articles for article (PubMed ID: 29040686)
1. The World Health Organization's Response to Emerging Human Immunodeficiency Virus Drug Resistance and a Call for Global Action.
Bertagnolio S; Beanland RL; Jordan MR; Doherty M; Hirnschall G
J Infect Dis; 2017 Dec; 216(suppl_9):S801-S804. PubMed ID: 29040686
[TBL] [Abstract][Full Text] [Related]
2. Progress of implementation of the World Health Organization strategy for HIV drug resistance control in Latin America and the Caribbean.
Ravasi G; Jack N; Alonso Gonzalez M; Sued O; Pérez-Rosales MD; Gomez B; Vila M; Riego Ad; Ghidinelli M
Rev Panam Salud Publica; 2011 Dec; 30(6):657-62. PubMed ID: 22358418
[TBL] [Abstract][Full Text] [Related]
3. The World Health Organization's global strategy for prevention and assessment of HIV drug resistance.
Bennett DE; Bertagnolio S; Sutherland D; Gilks CF
Antivir Ther; 2008; 13 Suppl 2():1-13. PubMed ID: 18578063
[TBL] [Abstract][Full Text] [Related]
4. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.
Jordan MR; Bennett DE; Bertagnolio S; Gilks CF; Sutherland D
Antivir Ther; 2008; 13 Suppl 2():15-23. PubMed ID: 18575188
[TBL] [Abstract][Full Text] [Related]
5. World Health Organization/HIVResNet Drug Resistance Laboratory Strategy.
Bertagnolio S; Derdelinckx I; Parker M; Fitzgibbon J; Fleury H; Peeters M; Schuurman R; Pillay D; Morris L; Tanuri A; Gershy-Damet GM; Nkengasong J; Gilks CF; Sutherland D; Sandstrom P
Antivir Ther; 2008; 13 Suppl 2():49-57. PubMed ID: 18575191
[TBL] [Abstract][Full Text] [Related]
6. Determinants of HIV drug resistance and public health implications in low- and middle-income countries.
Bertagnolio S; De Luca A; Vitoria M; Essajee S; Penazzato M; Hong SY; McClure C; Duncombe C; Jordan MR
Antivir Ther; 2012; 17(6):941-53. PubMed ID: 22898622
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of HIV drug resistance in low- and middle-income countries and WHO global strategy to monitor its emergence.
Bertagnolio S; Jordan MR; Giron A; Inzaule S
Curr Opin HIV AIDS; 2022 Jul; 17(4):229-239. PubMed ID: 35762378
[TBL] [Abstract][Full Text] [Related]
8. Expansion of Viral Load Testing and the Potential Impact on HIV Drug Resistance.
Raizes E; Hader S; Birx D
J Infect Dis; 2017 Dec; 216(suppl_9):S805-S807. PubMed ID: 29206999
[TBL] [Abstract][Full Text] [Related]
9. Implementing early-warning indicators of HIV drug resistance in the Caribbean.
Jack N; Ravasi G; Schrooten W; Sutherland D; Ghidinelli M; Del Riego A
Clin Infect Dis; 2012 May; 54 Suppl 4():S290-3. PubMed ID: 22544189
[TBL] [Abstract][Full Text] [Related]
10. Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011.
Jordan MR; Bennett DE; Wainberg MA; Havlir D; Hammer S; Yang C; Morris L; Peeters M; Wensing AM; Parkin N; Nachega JB; Phillips A; De Luca A; Geng E; Calmy A; Raizes E; Sandstrom P; Archibald CP; Perriëns J; McClure CM; Hong SY; McMahon JH; Dedes N; Sutherland D; Bertagnolio S
Clin Infect Dis; 2012 May; 54 Suppl 4(Suppl 4):S245-9. PubMed ID: 22544182
[TBL] [Abstract][Full Text] [Related]
11. A retrospective survey of HIV drug resistance among patients 1 year after initiation of antiretroviral therapy at 4 clinics in Malawi.
Wadonda-Kabondo N; Hedt BL; van Oosterhout JJ; Moyo K; Limbambala E; Bello G; Chilima B; Schouten E; Harries A; Massaquoi M; Porter C; Weigel R; Hosseinipour M; Aberle-Grasse J; Jordan MR; Kabuluzi S; Bennett DE
Clin Infect Dis; 2012 May; 54 Suppl 4(Suppl 4):S355-61. PubMed ID: 22544203
[TBL] [Abstract][Full Text] [Related]
12. Surveillance of HIV drug resistance in children receiving antiretroviral therapy: a pilot study of the World Health Organization's generic protocol in Maputo, Mozambique.
Vaz P; Augusto O; Bila D; Macassa E; Vubil A; Jani IV; Pillon R; Sandstrom P; Sutherland D; Giaquinto C; Jordan MR; Bertagnolio S
Clin Infect Dis; 2012 May; 54 Suppl 4(Suppl 4):S369-74. PubMed ID: 22544205
[TBL] [Abstract][Full Text] [Related]
13. Monitoring HIV Drug Resistance Early Warning Indicators in Cameroon: A Study Following the Revised World Health Organization Recommendations.
Fokam J; Elat JB; Billong SC; Kembou E; Nkwescheu AS; Obam NM; Essiane A; Torimiro JN; Ekanmian GK; Ndjolo A; Shiro KS; Bissek AC
PLoS One; 2015; 10(6):e0129210. PubMed ID: 26083364
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and characteristics of HIV drug resistance among antiretroviral treatment (ART) experienced adolescents and young adults living with HIV in Ndola, Zambia.
Miti S; Handema R; Mulenga L; Mwansa JK; Abrams E; Frimpong C; Burke VM; Zulu M; Siwingwa M; Mwakazanga D; Kalibala S; Denison JA
PLoS One; 2020; 15(8):e0236156. PubMed ID: 32804970
[TBL] [Abstract][Full Text] [Related]
15. The Critical Role of Supply Chains in Preventing Human Immunodeficiency Virus Drug Resistance in Low- and Middle-Income Settings.
Minior T; Douglas M; Edgil D; Srivastava M; Crowley J; Firth J; Lapidos-Salaiz I; Williams J; Lee L
J Infect Dis; 2017 Dec; 216(suppl_9):S812-S815. PubMed ID: 29029317
[TBL] [Abstract][Full Text] [Related]
16. Impact of Human Immunodeficiency Virus Drug Resistance on Treatment of Human Immunodeficiency Virus Infection in Children in Low- and Middle-Income Countries.
Siberry GK; Amzel A; Ramos A; Rivadeneira ED
J Infect Dis; 2017 Dec; 216(suppl_9):S838-S842. PubMed ID: 29045697
[TBL] [Abstract][Full Text] [Related]
17. The Impact of HIV-1 Drug Escape on the Global Treatment Landscape.
Collier DA; Monit C; Gupta RK
Cell Host Microbe; 2019 Jul; 26(1):48-60. PubMed ID: 31295424
[TBL] [Abstract][Full Text] [Related]
18. The global status of HIV drug resistance: clinical and public-health approaches for detection, treatment and prevention.
Hong SY; Nachega JB; Kelley K; Bertagnolio S; Marconi VC; Jordan MR
Infect Disord Drug Targets; 2011 Apr; 11(2):124-33. PubMed ID: 21406052
[TBL] [Abstract][Full Text] [Related]
19. Resistance to antiretroviral drugs in newly diagnosed, young treatment-naïve HIV-positive pregnant women in the province of KwaZulu-Natal, South Africa.
Parboosing R; Naidoo A; Gordon M; Taylor M; Vella V
J Med Virol; 2011 Sep; 83(9):1508-13. PubMed ID: 21739439
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of pre-treatment and acquired HIV drug resistance in Vietnam: a nationally representative survey, 2017-2018.
Dat VQ; Anh NTL; Van Nghia K; Linh NT; Thu HHK; Tam TTM; Ton T; Anh LQ; Phuc ND; Huong PTT; Nhan DT; Hai NH; Bertagnolio S; Crisp AM; Inzaule S; Dean NE; Jordan MR; Nguyen VTT
J Int AIDS Soc; 2022 Feb; 25(2):e25857. PubMed ID: 35194954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
